Tenofovir alafenamide prevents mother-to-infant HBV transmission

Tenofovir alafenamide prevents mother-to-infant HBV transmission

Tenofovir alafenamide therapy was safe, well-tolerated and prevented the transmission of hepatitis B virus from pregnant mothers to infants, according to research presented at The Liver Meeting Digital Experience.Currently, few data exist investigating the safety and effectiveness of tenofovir disoproxil fumarate (TDF) or tenofovir alafenamide (TAF) administration among pregnant women with chronic HBV despite being indicated for use during pregnancy in China, Qing-Lei Zeng, MD, associate professor at The First Affiliated Hospital of Zhengzhou University, said during the presentation. In aRead More

Share on facebook
Share on twitter
Share on linkedin